我们的结果提示合适的免疫抑制方案能够延长移植物的存活。
Our results suggest this immunosuppressive protocol may allow long-term graft survival.
术后有效的抗感染治疗和个体化免疫抑制方案是提高肝移植成功率的关键。
Effective anti-infective treatment and individualized immunosuppression after liver transplantation program is the key to improve the success rate.
目的评价非糖皮质激素的免疫抑制方案防止大鼠同种异体胰岛移植排斥反应的效果。
Objective To evaluate the effect of anti-rejection of glucocorticoid-free immunosuppressive regimen on allogenic islet transplantation.
结论：术后连续3 ~6天使用常规剂量al G是一种有效，安全价廉的免疫抑制方案。
Conclusion: Continuous using of common dose ALG for 3 ~ 6 days after operation has been an effective, safe and cheep immunosuppressive therapy.
目的比较HLA配型和免疫抑制方案相同情况下亲属活体供肾移植与尸体供肾移植的临床效果。
Objective To compare the clinical results between living related and cadaveric donor renal transplantation in the same immunosuppressive regimen and HLA match.
因此，如何调整免疫抑制方案，使其达到低毒化、个体化，成为目前移植工作者急需解决的问题。
Therefore, it is urgent for transplant workers to adjust the strategies and find a low toxicity and individualized immunosuppressive protocol.
因此一个理想的疗法应该具备以下几点：它是一个能防止潜在长期危险和排异反应并无需非特异型免疫抑制疗法的胰岛移植方案。
Thus, an optimal approach would involve an islet transplantation protocol that would prevent graft rejection without the need for potentially dangerous long-term and nonspecific immune suppression.
前不久，人们开始重新关注于抗体诱导在肝移植方面的应用，将其作为消除或减少一种或多种免疫抑制药物的治疗方案的一部分。
More recently there has been renewed interest in antibody induction in liver transplantation as part of a strategy to eliminate or reduce one or more immunosuppressive agents.
目的观察在应用巴利昔单抗的基础上，早期撤除激素的免疫抑制剂方案临床效果。
Objective To study the clinical efficacy of immunosuppressive regimen with early steroid withdrawal based on basiliximab.
《国际肝病》：您能谈一下关于肝癌肝移植术后免疫抑制剂方案应用的一些进展吗？
Hepatology Digest: Can you discuss some advances in immunosuppressive regimens in liver transplantation for HCC?
在美国，免疫抑制剂使用是相当规范和标准化了的，这就是像你刚才提及的预防排斥的方案，对吗？
Around U. S., the immunosuppression that is used is pretty standardized, and so prevent the rejection as you referred to right?
补充外源性IL- 10并联合应用低剂量免疫抑制药物方案对同种异体移植肝长期存活是有用的。
Supplementary exogenous IL-10 administration combined with low-dose immunosuppressive drug may be a useful strategy to induce long-term liver allograft survival.
补充外源性IL- 10并联合应用低剂量免疫抑制药物方案对同种异体移植肝长期存活是有用的。
Supplementary exogenous IL-10 administration combined with low-dose immunosuppressive drug may be a useful strategy to induce long-term liver allograft survival.
应用推荐